Nyxoah, a pioneering Med Tech company focused on Obstructive Sleep Apnea solutions, has secured a €37.5 million loan facility agreement from the European Investment Bank (EIB).
Key Opinion Leader (KOL) Prof. Dr. Olivier M. Vanderveken, MD, PhD, is a full-time ENT, Head and Neck Surgeon at the Antwerp University Hospital in Belgium. He is appointed as Chairman of the Department of ENT-HNS at Antwerp University Hospital and an expert in the field of Hypoglossal Nerve Stimulation(HGNS). Prof. Vanderveken offers his expert insights into this strategic funding, highlighting its potential to drive forward innovative research and development. Prof. Vanderveken emphasizes the critical impact of this investment on advancing clinical trials, enhancing technological capabilities, and ultimately improving patient care for those suffering from Obstructive Sleep Apnea. #Nyxoah #genio #sleepapneatreatment #entsurgeon #HGNS #osa #sleepapnea #innovationinhealth #patientcare

свернуть